Sientra Reports Fourth Quarter and Full Year 2017 Financial Results

- March 14th, 2018

Sientra (NASDAQ:SIEN) a medical aesthetics company, today announced its financial results for the fourth quarter and full year ended December 31, 2017. As quoted in the press release: Jeffrey M. Nugent, Chairman and Chief Executive Officer of Sientra, said, “I am proud of our team’s accomplishments through 2017 that helped Sientra’s progress to become a … Continued

Sientra (NASDAQ:SIEN) a medical aesthetics company, today announced its financial results for the fourth quarter and full year ended December 31, 2017.

As quoted in the press release:

Jeffrey M. Nugent, Chairman and Chief Executive Officer of Sientra, said, “I am proud of our team’s accomplishments through 2017 that helped Sientra’s progress to become a leading global aesthetics company. Sientra’s base portfolio has been strengthened through diversification and is showing traction in all categories as a result of our continued strong relationships and credibility within our targeted professional sectors. We have completed the majority of the requirements needed for full FDA approval of our breast implant products. Our site-change PMA supplement and two of three smaller submissions for manufacturing process improvements have been approved and shortened the timeline to our relaunch into the breast implant market. We look forward to begin selling our U.S. manufactured silicone gel breast implants and offering our customers and their patients with the well-documented Sientra advantages.”

Click here to read the full press release.

Read our FREE medical device report today

 

 

Get My Free Report  

Leave a Reply